Impact of Ciprofol Versus Propofol on Heart Injury After Video-Assisted Thoracoscopic Surgery in Adults Aged 45 to 80
Led by Tongji Hospital · Updated on 2026-01-28
1058
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effects of Ciprofol, a new intravenous anesthetic drug, on myocardial injury occurring after non-cardiac thoracic surgery. Myocardial injury after noncardiac surgery MINS is identified by elevated cardiac troponin levels due to ischemic causes and is a common complication after thoracic surgery, linked to increased risks of mortality and vascular problems. This study aims to see if Ciprofol can reduce the incidence of MINS compared to propofol, focusing on patients undergoing video-assisted thoracoscopic surgery VATS for lung cancer treatment.
Participants will be randomly assigned to receive either Ciprofol or propofol as sedative agents during general anesthesia for VATS. Both groups will also receive sufentanil and cis-atracurium intravenously. The doses and administration times for study drugs are carefully controlled. The trial is double-blind and multicenter, comparing the circulatory stability and sedative effects of Ciprofol with those of propofol in thoracic surgery patients.
During the study, patients will be monitored for myocardial injury within 30 days post-surgery, as well as for new heart rhythm problems, episodes of low blood pressure, and mortality rates. Data on anesthesia induction, maintenance, and perioperative hemodynamics will be collected. The study includes baseline assessments and safety monitoring, with follow-up visits lasting at least three days postoperatively. Researchers will analyze the incidence of myocardial injury and other cardiovascular outcomes to assess the impact of Ciprofol on patient safety and recovery.
CONDITIONS
Brief Title
Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic Surgery
Research Team
A
Ailin Luo, MD&PhD
S
Shiyong Li, MD&PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Scheduled for elective video-assisted thoracoscopic thoracic surgery including lobectomy, segmentectomy, wedge resection of two or more lung tissues, or mediastinal tumor resection under general anesthesia
Aged 45 to 80 years at the time of randomization
Expected to stay in the hospital for at least 3 days after surgery
Signed a written informed consent form to participate in the study
You will not qualify if you...
Allergy to propofol, Ciprofol, or related drug components such as soybeans, eggs, or milk
Unstable angina
Congestive heart failure or hemodynamic instability requiring vasopressor medications
Severe chronic obstructive pulmonary disease with FEV1 less than 1 liter
Severe liver dysfunction with ALT or AST levels exceeding 1.5 times the upper limit of normal
Planning to conceive within the next 3 months (male or female)
Pregnant or breastfeeding females
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Day of surgery
Participants undergo video-assisted thoracoscopic surgery with anesthesia induced and maintained using either Ciprofol or Propofol as sedative agents.
1 surgical visit (in-person)
Post-operative Follow-up
Duration - Up to 30 days after surgery
Participants are monitored for myocardial injury and cardiovascular complications following surgery.
Multiple visits during hospital stay and follow-up visits up to 30 days
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Use of Atomized Inhalation Indocyanine Green ICG in Thoracoscopic Surgery to Treat Congenital Lung Malformations in Children
Prospective Study on Treatments and Outcomes in Carbon Monoxide Poisoning Patients in Korea
Study of Colchicine to Reduce Heart Injury and Major Cardiac Events in Patients at Risk Undergoing Major Non-Heart Surgery
Study of Selective C-Reactive Protein Apheresis Using the PentraSorb System in Patients With ST-Elevation Myocardial Infarction Treated With Primary PCI
Study of Manual Chest Wall Vibration Effects on Breathing and Chest Tube Duration After Thoracic Surgery
Study of High-dose Nicotine Patch Effects on Pain After Thoracic Surgery in Male Tobacco Smokers Aged 18 to 75
Impact of Ciprofol Versus Propofol on Heart Injury After Video-Assisted Thoracoscopic Surgery in Adults Aged 45 to 80
Low-dose Esmolol to Prevent Heart Injury After Non-Heart Surgery in Frail Older Adults
A Multicenter, Randomized, Double-blind Study
Study of Endothelial Dysfunction and Its Link to Heart and Brain Events After Non-Cardiac Surgery in Adults 45 and Older
Study of Erector Spinae Blocks with Bupivacaine to Reduce Pain After Pulmonary Resection Surgery
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Safety and efficacy of ciprofol vs. propofol for sedation in intensive care unit patients with mechanical ventilation: a multi-center, open label, randomized, phase 2 trial.
Efficacy and safety of ciprofol vs. propofol for the induction and maintenance of general anaesthesia: A multicentre, single-blind, randomised, parallel-group, phase 3 clinical trial.
Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study.
Efficacy and safety of HSK3486 for the induction and maintenance of general anesthesia in elective surgical patients: a multicenter, randomized, open-label, propofol-controlled phase 2 clinical trial.
Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial.